Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camrelizumab and Apatinib With or Without FOLFOX for Advanced HCC
NCT07267806Phase 3Recruiting
- Start
- Oct 2025
- Primary completion
- Oct 2029
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil in hepatocellular carcinoma (HCC). Started Oct 2025; status: recruiting.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07267806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07267806.